For Asthma Monitoring

Real-World Insights into Asthma Symptoms with the RESP® Biosensor

Asthma poses a huge burden on society and healthcare systems affecting 300 million globally, with prevalence and disease burden continuing to rise.1 Highly common in children, the disease is among the top causes of pediatric ED visits and missed school days.2

As clinicians and life sciences professionals seek more effective asthma remote monitoring tools, wearable devices that continuously track symptoms like cough, wheeze and breathing patterns are emerging as valuable solutions. The RESP® Biosensor functions as both a wheeze detector and cough monitoring device, offering objective data beyond what can be captured through intermittent auscultation or patient-reported outcomes (PROs). In addition to providing objective insight into symptom burden alongside PROs, increasing research shows that symptoms such as wheeze, cough and shortness of breath are associated with exacerbations.³

The RESP® Biosensor is an asthma wearable device designed for remote monitoring, providing direct, reliable metrics on cough and wheeze to complement patient self-reporting and pulmonary function tests for a more complete picture of disease burden.

The RESP® Biosensor: Technology Overview

  • Clinically validated asthma wearable device, with equivalent performance to Littman 3200 electronic stethoscope¹
  • Passive collection of lung sounds such as cough and wheeze to offer objective data on respiratory status passively and remotely
  • Patient-friendly form factor: wireless and discreet without interfering with daily life

1. M. Glass, et al. Results of Clinical Performance Testing of a Novel Wearable e-Stethoscope in Patients with Chronic Lung Diseases [abstract]. Am J Respir Crit Care Med

Wheeze Monitor & Asthma Monitoring Device

How It Works

An end-to-end solution for asthma remote monitoring

RESP® Biosensor

Wearable biosensor passively and continuously collects lung sounds including wheeze 

RESP® Cloud

Captured data are securely and wirelessly transferred to HIPAA-compliant cloud for overread

Patient Reports

Once overread is complete, client receives detailed patient reports on wheezing, cough and other metrics

Initial results from the study which took place at Ann & Lurie Children’s Hospital in Chicago showed positive feedback from patients and families as well as strong accuracy in wheeze detection compared to physician auscultation.

TESTIMONIAL VIDEO

Hear from Sadia Benzaquen, MD, Director of Pulmonary & Critical Care at Einstein Philadelphia Hospital

Interested in a Research Collaboration?

We’re seeking clinical and academic collaborators to explore how wearable asthma monitors can improve patient outcomes. Partners may be eligible for in-kind support.

For Healthcare

Wearable asthma remote monitoring to enhance surveillance of at-risk patients

Learn More

For Life Sciences

Collect novel insights into subject treatment response in clinical trials for asthma

Learn More

Fit-for-Purpose Asthma Remote Monitoring

Patient reports include accurate, time-stamped data on signs and symptoms such as coughing and wheezing, allowing for greater diagnostics and insight into treatment response.

Strados RESP biosensor data

Is the RESP® Biosensor reimbursable?

The RESP® Biosensor is reimbursable under RPM and RTM codes.

Is the RESP® Biosensor designed for continuous long-term monitoring?

Yes. The RESP® Biosensor was designed for long-term, continuous remote monitoring with the goal of detecting changes in lung sounds passively ranging from 4 – 24 hours per day. 

Which care settings is the RESP® Biosensor intended for?

The RESP® Biosensor is designed to be used across multiple care settings, including clinical trials,  in-patient, transitional care, post-acute discharge, outpatient, and hospital at home

Let’s Connect

Explore using the RESP® Biosensor in your study or practice 

References

  1. Wang, Z., Li, Y., Gao, Y., Fu, Y., Lin, J., Lei, X., Zheng, J., & Jiang, M. (2023). Global, regional, and national burden of asthma and its attributable risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. Respiratory research, 24(1), 169. https://doi.org/10.1186/s12931-023-02475-6
  2. Asthma and Allergy Foundation of America. Asthma Facts and Figures [Internet] Available at https://aafa.org/asthma/asthma-facts/
  3. NHS. Asthma Attacks [Internet]. https://www.nhs.uk/conditions/asthma/asthma-attack/